AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRBU
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Caribou Biosciences, Inc. stock price on Monday which ended trading at $3.13
(Updated on May 20, 2024)

Sell candidate since May 17, 2024 Loss -7.67% PDF

The Caribou Biosciences, Inc. stock price fell by -7.67% on the last day (Monday, 20th May 2024) from $3.39 to $3.13. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 14.24% from a day low at $3.02 to a day high of $3.45. The price has fallen in 7 of the last 10 days and is down by -18.28% for this period. Volume has increased on the last day by 5 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 8 million shares were bought and sold for approximately $23.67 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -53.43% during the next 3 months and, with a 90% probability hold a price between $0.690 and $1.86 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRBU Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Caribou Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.52 and $3.92. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -62.11%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Caribou Biosciences, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.430 between high and low, or 14.24%. For the last week, the stock has had daily average volatility of 8.38%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRBU) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Caribou Biosciences, Inc. to open at $3.20, and during the day (based on 14 day Average True Range), to move between $2.86 and $3.40, which gives a possible trading interval of +/-$0.268 (+/-8.55%) up or down from last closing price. If Caribou Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 17.10% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $3.64, some $0.510 (16.29%) from the current price of $3.13, our system finds the risk reward not very attractive.

Is Caribou Biosciences, Inc. stock A Buy?

Caribou Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -7.746 Strong Sell Candidate Downgraded

Predicted Opening Price for Caribou Biosciences, Inc. of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
$3.20 ( 2.24%) $3.13

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRBU

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.63 15.97 %
R2 3.47 10.73 %
R1 3.36 7.48 %
Current price: 3.13
Support S1 3.04 -3.01 %
S2 2.93 -6.25 %
S3 2.77 -11.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.91 24.92 %
R2 3.71 18.53 %
R1 3.64 16.29 %
Current price 3.13
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Caribou Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Caribou Biosciences, Inc. is CRBU and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Caribou Biosciences, Inc. Stock?
Caribou Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Caribou Biosciences, Inc. Stock?
Caribou Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Caribou Biosciences, Inc. Stock.

What's the current price of Caribou Biosciences, Inc. Stock?
As of the end of day on the May 20, 2024, the price of an Caribou Biosciences, Inc. (CRBU) share was $3.13.

What is the 52-week high and low for Caribou Biosciences, Inc. Stock?
The 52-week high for Caribou Biosciences, Inc. Stock is $8.59 and the 52-week low is $3.02.

What is the market capitalization of Caribou Biosciences, Inc. Stock?
As of the May 20, 2024, the market capitalization of Caribou Biosciences, Inc. is 282.695M.

When is the next earnings date for Caribou Biosciences, Inc.?
The upcoming earnings date for Caribou Biosciences, Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Caribou Biosciences, Inc.

Caribou Biosciences. Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic ... CRBU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT